Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 16/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29876633 | 0.91 | LTA4H (0.62) | CTSDLTA4H | |
| SCHEMBL31720963 | 0.89 | CTSD (0.58) | CTSDLTA4HCTSBCTSK | |
| SCHEMBL30051502 | 0.89 | CTSD (0.59) | CTSDLTA4H | |
| SCHEMBL34467263 | 0.86 | ACE (0.61) | CTSD | |
| SCHEMBL30369261 | 0.86 | CTSD (0.64) | CTSDCTSBCTSK | |
| SCHEMBL30051590 | 0.85 | ACE (0.64) | CTSD | |
| SCHEMBL30272462 | 0.85 | CTSD (0.59) | CTSDLTA4HCTSBCTSK | |
| SCHEMBL30368747 | 0.85 | CTSD (0.63) | CTSDCTSBCTSK | |
| SCHEMBL14436730 | 0.85 | CTSD (0.49) | CTSDMMP1MMP2MMP3CTSB | |
| SCHEMBL30053045 | 0.84 | CTSD (0.61) | CTSDLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | TECHNISCHE UNIVERSITAT WIEN (AT) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | SLC1A2, NR1H4, OXGR1 | CTSD 4401/4885MMP1 4424/4885MMP2 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.